Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Invested Capital (2020 - 2025)

Historic Invested Capital for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $91.0 million.

  • Treace Medical Concepts' Invested Capital fell 1327.0% to $91.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.0 million, marking a year-over-year decrease of 1327.0%. This contributed to the annual value of $112.9 million for FY2024, which is 1815.74% down from last year.
  • Latest data reveals that Treace Medical Concepts reported Invested Capital of $91.0 million as of Q3 2025, which was down 1327.0% from $98.7 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Invested Capital registered a high of $157.6 million during Q1 2023, and its lowest value of $28.5 million during Q1 2021.
  • Its 5-year average for Invested Capital is $102.0 million, with a median of $102.9 million in 2021.
  • As far as peak fluctuations go, Treace Medical Concepts' Invested Capital skyrocketed by 13016708.86% in 2021, and later plummeted by 3612.09% in 2022.
  • Over the past 5 years, Treace Medical Concepts' Invested Capital (Quarter) stood at $93.1 million in 2021, then crashed by 34.97% to $60.5 million in 2022, then skyrocketed by 127.89% to $137.9 million in 2023, then fell by 18.16% to $112.9 million in 2024, then fell by 19.41% to $91.0 million in 2025.
  • Its last three reported values are $91.0 million in Q3 2025, $98.7 million for Q2 2025, and $105.4 million during Q1 2025.